help with home work
3 months ago
15
Nu553Assignment2.docx
NU553_Unit_2_Template.docx
Nu553Assignment2.docx
Nu 553 Assignment 2
In this assignment you will explore the ethical, legal, and regulatory aspects and cost-effective benefits of prescribing practices of the advanced practice nurse with regards to antibiotic stewardship.
You will address ethical prescribing practices and complete a comparison table in a provided template.
· Access the Unit 2 template and ensure you complete your name and the required information. Use the headers in the template provided.
· Begin with an introductory paragraph on general considerations related to safe antibiotic prescribing.
· Next include content on ethical, legal, and regulatory aspects of prescribing.
· Address how it is important for you to demonstrate civility in communication with patients and other disciplines when prescribing.
· Address cost-effective benefits of prescribing practices. Include brand vs generic aspects.
· Next address antibiotic stewardship and prescribing practices. Include content on reducing resistance, commitment as a prescriber and how to follow evidence based practice in prescribing antibiotics.
· Provide 4-5 sentences per section.
· Then complete the table component within the template.
· Refer to your text and readings to help you choose a drug from the class. Include 2-4 items/ key points per section based on your literature search.
· The template sections will expand as you add content. Use key words with bulleted content or brief descriptions. Do not paste large content.
· You will have completed 10 drugs yourself when done.
· Penicillin is done for you as an example. Keep it on the table to help you.
· You may add the citation under the drug names as in the PCN example. Include references on your reference page.
· Keep the headings within the essay portion bolded. Polish and keep the template and the table neat. Be sure the font is Ariel 10 within the table. It should be readable, meaningful, organized and not wordy.
Assignment Details
Prescribing Practice Considerations - Evidence Based Antimicrobial Therapy
NU553-1: Explore the ethical, legal, and regulatory aspects and cost-effective benefits of prescribing practices of the advanced practice nurse.
Before finalizing your work, you should:
· Read the directions carefully
· Consult the grading rubric and review your completed work to make sure you have included everything necessary
· Utilize spelling and grammar checks to minimize errors.
Your writing assignment should:
· Follow the conventions of Standard English (correct grammar, punctuation, etc.);
· Be well ordered, logical, and unified, as well as original and insightful;
· Display superior content, organization, style, and mechanics;
· Use the template provided;
· Use APA 7th edition format.
NU553_Unit_2_Template.docx
NU553 Unit 2 Template
Review the grading rubric.
Antimicrobials and Antibiotic Stewardship
Student Name:
Date:
Instructor Name:
Introduction.
Legal/ Ethical and Regulatory Considerations.
Communication Civility
Cost- Effective Benefits.
Antimicrobial Stewardship.
|
Antimicrobial Agents |
||||||
|
Drug Class
Drug Name Brand/ Generic
|
Mechanism of action
|
Pharmacokinetics Key points |
Microbiology Key points |
Indications and Uses |
Dose via Age and Dose Considerations |
Warnings |
|
Penicillins
Penicillin G
(Penicillin G 2025) |
Beta-lactam antibiotic, interferes with bacteria cell wall synthesis ultimately leading to cell lysis
|
Protein bound to albumin in circulation
Crosses placenta and breast milk
Excreted in urine primarily |
Gram + Bacteria.Streptococcus pyogenes,S. pneumoniaeenterococcalSome gram-neg: meningeal cocci |
treponemal infections-syphilis meningococcal bacteremiaEndocarditis Botulism Pneumonia |
4-24 million units per day based on indication.
IV most often since poorly absorbed in the gut
Can be IM for short term indication |
Allergy
CHF related due to sodium content
Dose adjustment for renal impairment
|
|
Beta-Lactam/ Beta Lactamase Inhibitor |
|
|
|
|
|
|
|
1st Generation Cephalosporin |
|
|
|
|
|
|
|
Fluoroquinolone |
|
|
|
|
|
|
|
Macrolide |
|
|
|
|
|
|
|
Aminoglycoside |
|
|
|
|
|
|
|
Tetracycline |
|
|
|
|
|
|
|
Sulfonamide
|
|
|
|
|
|
|
|
Fusion Inhibitor
|
|
|
|
|
|
|
|
Nucleoside Analogs |
|
|
|
|
|
|
|
Protease Inhibitor |
|
|
|
|
|
|
References
Penicillin G. (2025). Merck Manual https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-medications/penicillins?query=pen%20vk#Pharmacokinetics_v13957234